Holen Sie sich die Stockscreener-App
5.55
3.54%
0.19
Handel nachbörslich:
5.57
0.02
+0.36%
Schlusskurs vom Vortag:
$5.36
Offen:
$5.36
24-Stunden-Volumen:
3.19M
Relative Volume:
0.63
Marktkapitalisierung:
$1.66B
Einnahmen:
$38.03M
Nettoeinkommen (Verlust:
$-146.40M
KGV:
-10.67
EPS:
-0.52
Netto-Cashflow:
$-121.38M
1W Leistung:
-1.94%
1M Leistung:
+10.34%
6M Leistung:
+112.64%
1J Leistung:
+103.30%
1-Tages-Spanne:
$5.358
$5.675
1-Wochen-Bereich:
$5.34
$5.80
52-Wochen-Spanne:
$1.8906
$6.515
Abcellera Biologics Inc Stock (ABCL) Company Profile
Firmenname
Abcellera Biologics Inc
Sektor
Branche
Telefon
(604) 559-9005
Adresse
150 W 4TH AVENUE, VANCOUVER
Vergleichen Sie ABCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
5.55 | 1.60B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-20 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-02-22 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-10-13 | Fortgesetzt | Piper Sandler | Overweight |
| 2023-02-28 | Eingeleitet | Cowen | Outperform |
| 2022-12-15 | Eingeleitet | Goldman | Buy |
| 2022-11-16 | Eingeleitet | Truist | Buy |
| 2021-12-21 | Eingeleitet | The Benchmark Company | Buy |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-01-05 | Eingeleitet | Berenberg | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-05 | Eingeleitet | SVB Leerink | Outperform |
| 2021-01-05 | Eingeleitet | Stifel | Buy |
Alle ansehen
Abcellera Biologics Inc Aktie (ABCL) Neueste Nachrichten
Is AbCellera Biologics Inc. (8QQ) stock dividend growth reliableJuly 2025 Closing Moves & Target Return Focused Stock Picks - newser.com
Understanding AbCellera Biologics Inc.’s price movementWeekly Risk Report & Safe Entry Momentum Tips - newser.com
Real time breakdown of AbCellera Biologics Inc. stock performanceEarnings Overview Summary & Step-by-Step Swing Trade Plans - newser.com
What to do if you’re stuck in AbCellera Biologics Inc.July 2025 Price Swings & Consistent Growth Equity Picks - newser.com
What dividend safety rating applies to AbCellera Biologics Inc. (8QQ) stock2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
Will AbCellera Biologics Inc. (8QQ) stock hit Wall Street targetsWeekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
AbCellera Biologics Inc. stock volume spike explained2025 Big Picture & Free AI Powered Buy and Sell Recommendations - newser.com
Is AbCellera Biologics Inc. a candidate for recovery playMarket Trend Report & Weekly Top Stock Performers List - newser.com
Can AbCellera Biologics Inc. (8QQ) stock resist broad market declinesJuly 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Risk adjusted return profile for AbCellera Biologics Inc. analyzedMarket Trend Summary & Daily Profit Maximizing Trade Tips - newser.com
Is it time to cut losses on AbCellera Biologics Inc.Analyst Upgrade & Smart Allocation Stock Tips - newser.com
Using flow based indicators on AbCellera Biologics Inc.Rate Hike & Daily Growth Stock Investment Tips - newser.com
Is a relief rally coming for AbCellera Biologics Inc. holdersJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - newser.com
AbCellera Biologics (ABCL) to Release Quarterly Earnings on Thursday - MarketBeat
How AbCellera Biologics Inc. stock reacts to Fed rate cutsWatch List & Fast Moving Stock Trade Plans - newser.com
What earnings revisions data tells us about AbCellera Biologics Inc.Quarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com
Can volume confirm reversal in AbCellera Biologics Inc.Watch List & Target Return Focused Picks - newser.com
Will AbCellera Biologics Inc. see short term momentumVolume Spike & Precise Buy Zone Identification - newser.com
How to interpret RSI for AbCellera Biologics Inc. stockJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Will AbCellera Biologics Inc. stock maintain momentum in 2025M&A Rumor & AI Driven Stock Reports - newser.com
Is AbCellera Biologics Inc. (8QQ) stock in buy zone after pullbackJuly 2025 Spike Watch & Long-Term Safe Return Strategies - newser.com
Finanzdaten der Abcellera Biologics Inc-Aktie (ABCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):